The benefits, costs and feasibility of a low incidence COVID-19 strategy

• Main Authors: Thomas Czypionka (Author), Emil N. Iftekhar (Author), Barbara Prainsack (Author), Viola Priesemann (Author), Simon Bauer (Author), André Calero Valdez (Author), Sarah Cuschieri (Author), Enrico Glaab (Author), Eva Grill (Author), Jenny Krutzinna (Author), Christos Lionis (Author), Helena Machado (Author), Carlos Martins (Author), George N. Pavlakis (Author), Matjaž Perc (Author), Elena Petelos (Author), Martyn Pickersgill (Author), Alexander Skupin (Author), Eva Schernhammer (Author), Ewa Szczurek (Author), Sotirios Tsiodras (Author), Peter Willeit (Author), Paul Wilmes (Author)
• Format: Book
• Published: Elsevier, 2022-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: In the summer of 2021, European governments removed most NPIs after experiencing prolonged second and third waves of the COVID-19 pandemic. Most countries failed to achieve immunization rates high enough to avoid resurgence of the virus. Public health strategies for autumn and winter 2021 h...